Skip NavigationSkip to Content

Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV

  1. Author:
    Kim, JungHyun
    Bu, Wei
    Mine, Sohtaro
    Tariq, Zeshan
    Nguyen, Hanh
    Wang,Yanmei
    Tolman, Cynthia
    Mond, James
    Cohen, Jeffrey I.
  2. Author Address

    NIH, Med Virol Sect, Lab Infect Dis, Bethesda, MD 20892 USA.Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20740 USA.Frederick Natl Lab Canc Res, Clin Serv Program, Leidos Biomed Res, Frederick, MD 21702 USA.ADMA Biol, Boca Raton, FL 33487 USA.
    1. Year: 2021
    2. Date: Sep
    3. Epub Date: 2021 06 20
  1. Journal: VIROLOGY
  2. ACADEMIC PRESS INC ELSEVIER SCIENCE,
    1. 561
    2. Pages: 80-86
  3. Type of Article: Article
  4. ISSN: 0042-6822
  1. Abstract:

    Primary infection with Epstein-Barr virus (EBV) is associated with post-transplant lymphoproliferative disease and severe disease in patients with X-linked lymphoproliferative disease; no therapies are approved to prevent EBV infection in these patients. Hyperimmune globulin has been used to prevent some virus infections in immunocompromised persons. Here, we identified plasma donors with high titers of EBV gp350 and EBV B cell neutralizing antibodies. Pooled IgG isolated from these donors was compared to intravenous immunoglobulin (IVIG) for its ability to reduce viral load in the blood in humanized mice challenged with EBV. Mice that received EBV hyperimmune globulin had significantly reduced EBV DNA copy numbers compared to animals that received saline control; however, while animals that received EBV hyperimmune globulin had lower EBV DNA copies than those that received IVIG, the difference was not significant. Thus, while EBV hyperimmune globulin reduced viral load compared to IVIG, the effect was modest.

    See More

External Sources

  1. DOI: 10.1016/j.virol.2021.06.006
  2. WOS: 000670888800010

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel